China Universal Asset Management Co., Ltd. Supernus Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 19,866 shares of SUPN stock, worth $774,774. This represents 0.07% of its overall portfolio holdings.
Number of Shares
19,866
Previous 10,599
87.43%
Holding current value
$774,774
Previous $330,000
117.58%
% of portfolio
0.07%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding SUPN
# of Institutions
284Shares Held
60.5MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$405 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$239 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$199 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$112 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$103 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.09B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...